CZ20031277A3 - Postup přípravy latentního antitrombinu III postup přípravy - Google Patents

Postup přípravy latentního antitrombinu III postup přípravy Download PDF

Info

Publication number
CZ20031277A3
CZ20031277A3 CZ20031277A CZ20031277A CZ20031277A3 CZ 20031277 A3 CZ20031277 A3 CZ 20031277A3 CZ 20031277 A CZ20031277 A CZ 20031277A CZ 20031277 A CZ20031277 A CZ 20031277A CZ 20031277 A3 CZ20031277 A3 CZ 20031277A3
Authority
CZ
Czechia
Prior art keywords
sample
sulfate
buffer
hepes
range
Prior art date
Application number
CZ20031277A
Other languages
Czech (cs)
English (en)
Inventor
Göran Karlsson
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0004086A external-priority patent/SE0004086D0/xx
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of CZ20031277A3 publication Critical patent/CZ20031277A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8128—Antithrombin III
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CZ20031277A 2000-11-08 2001-11-08 Postup přípravy latentního antitrombinu III postup přípravy CZ20031277A3 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0004086A SE0004086D0 (sv) 2000-11-08 2000-11-08 Preparation process
US25214800P 2000-11-20 2000-11-20

Publications (1)

Publication Number Publication Date
CZ20031277A3 true CZ20031277A3 (cs) 2003-08-13

Family

ID=26655296

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20031277A CZ20031277A3 (cs) 2000-11-08 2001-11-08 Postup přípravy latentního antitrombinu III postup přípravy

Country Status (15)

Country Link
EP (1) EP1332159A1 (ja)
JP (1) JP2004522707A (ja)
KR (1) KR20030057545A (ja)
AU (1) AU2002214468A1 (ja)
BR (1) BR0115188A (ja)
CA (1) CA2428055A1 (ja)
CZ (1) CZ20031277A3 (ja)
EE (1) EE200300218A (ja)
HU (1) HUP0301766A3 (ja)
IL (1) IL155539A0 (ja)
MX (1) MXPA03004030A (ja)
NO (1) NO20032048D0 (ja)
PL (1) PL360410A1 (ja)
RU (1) RU2003117016A (ja)
WO (1) WO2002038610A1 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
SE0203770D0 (sv) * 2002-12-19 2002-12-19 Biovitrum Ab Method of separation
EP1848473B1 (en) 2005-02-07 2013-05-22 Hanuman LLC Plasma concentrator device
US7694828B2 (en) 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
JP5479319B2 (ja) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー ブイ式懸濁液分画システム
WO2009108890A1 (en) 2008-02-27 2009-09-03 Biomet Biologics, Llc Methods and compositions for delivering interleukin-1 receptor antagonist
WO2009111338A1 (en) 2008-02-29 2009-09-11 Biomet Manufacturing Corp. A system and process for separating a material
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device

Also Published As

Publication number Publication date
IL155539A0 (en) 2003-11-23
NO20032048L (no) 2003-05-07
RU2003117016A (ru) 2004-12-10
HUP0301766A2 (hu) 2003-08-28
AU2002214468A1 (en) 2002-05-21
HUP0301766A3 (en) 2005-12-28
WO2002038610A1 (en) 2002-05-16
KR20030057545A (ko) 2003-07-04
CA2428055A1 (en) 2002-05-16
NO20032048D0 (no) 2003-05-07
BR0115188A (pt) 2004-02-03
EE200300218A (et) 2003-08-15
EP1332159A1 (en) 2003-08-06
MXPA03004030A (es) 2004-02-12
JP2004522707A (ja) 2004-07-29
PL360410A1 (en) 2004-09-06

Similar Documents

Publication Publication Date Title
CZ20031277A3 (cs) Postup přípravy latentního antitrombinu III postup přípravy
US20020090711A1 (en) Process for preparing latent antithrombin III
US6399357B1 (en) Filtration
JP2009524622A (ja) 創傷治癒支援因子の精製および使用
NZ295810A (en) Method of purifying factor viii using hydrophobic interaction chromatography gel with at least one surfactant in the chromatography solution
JPH10509144A (ja) ▲ｖｉｉｉ▼因子の精製方法
WO2002060925A1 (en) Method of producing latent antithrombin iii
US5777081A (en) Process for producing an inter-alpha-trypsin inhibitor concentrate for therapeutic use and concentrate thus obtained
US8076462B2 (en) Method for producing antithrombin composition
WO2014089956A1 (zh) 一种制备α1-抗胰蛋白酶的方法
AU682368B2 (en) Thrombin inhibitors
EP0282363B1 (fr) Procédé d'obtention d'un concentré d'alpha 1-antitrypsine à partir d'une fraction de plasma humain et son utilisation à titre de médicament
Karlsson et al. Separation of latent, prelatent, and native forms of human antithrombin by heparin affinity high-performance liquid chromatography
JP6096613B2 (ja) 細胞培養由来のアルファ１プロテアーゼ阻害剤の精製
ZA200303492B (en) Process for the preparation of latent antithrombin III.
Karlsson et al. Separation between the α and β forms of human antithrombin by hydroxyapatite high-performance liquid chromatography
AU777294B2 (en) Process for the purification of antithrombin-III
Karlsson et al. Preparative conversion of native human antithrombin to the latent form
Karlsson Pasteurization of antithrombin without generation of the prelatent form of antithrombin
CA2395489A1 (en) Process for the purification of antothrombin-iii
WO2023200908A1 (en) Methods of preparing albumin preparations
JP2022551566A (ja) 第ＸＩａ因子のヘパリン非感受性アッセイ
AU682274C (en) Filtration
WO2004056870A2 (en) Method for separation of antithrombin
WO2000043412A1 (fr) Compositions contenant du cofacteur ii de l'heparine hautement purifie et technique de separation associee